An Economic Evaluation of an Intervention to Increase Demand for Medical Male Circumcision Among Men Aged 25-49 Years in South Africa

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2021 Oct 16

PMID 34654429

Authors

M Holmes

R Mukora

D Mudzengi

S Charalambous

C M Chetty-Makkan

H Kisbey-Green

M Maraisane

J Grund

Affiliations

Soon will be listed here.

Abstract

Background: Studies estimate that circumcising men between the ages of 20-30 years who have exhibited previous risky sexual behaviour could reduce overall HIV prevalence. Demand creation strategies for medical male circumcision (MMC) targeting men in this age group may significantly impact these prevalence rates.

Objectives: The objective of this study is to evaluate the cost-effectiveness and cost-benefit of an implementation science, pre-post study designed to increase the uptake of male circumcision for ages 25-49 at a fixed MMC clinic located in Gauteng Province, South Africa.

Methods: A health care provider perspective was utilised to collect all costs. Costs were compared between the standard care scenario of routine outreach strategies and a full intervention strategy. Cost-effectiveness was measured as cost per mature man enrolled and cost per mature man circumcised. A cost-benefit analysis was employed by using the Bernoulli model to estimate the cases of HIV averted due to medical male circumcision (MMC), and subsequently translated to averted medical costs.

Results: In the 2015 intervention, the cost of the intervention was $9445 for 722 men. The total HIV treatment costs averted due to the intervention were $542,491 from a public care model and $378,073 from a private care model. The benefit-cost ratio was 57.44 for the public care model and 40.03 for the private care model. The net savings of the intervention were $533,046 or $368,628 - depending on treatment in a public or private setting.

Conclusions: The intervention was cost-effective compared to similar MMC demand interventions and led to statistically significant cost savings per individual enrolled.

References

Weller S, Davis K . Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002; (1):CD003255. DOI: 10.1002/14651858.CD003255. View

Kripke K, Chen P, Vazzano A, Thambinayagam A, Pillay Y, Loykissoonlal D . Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces. PLoS One. 2016; 11(7):e0157071. PMC: 4943592. DOI: 10.1371/journal.pone.0157071. View

Haacker M, Fraser-Hurt N, Gorgens M . Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis. PLoS Med. 2016; 13(5):e1002012. PMC: 4854479. DOI: 10.1371/journal.pmed.1002012. View

Bollinger L, Adesina A, Forsythe S, Godbole R, Reuben E, Njeuhmeli E . Cost drivers for voluntary medical male circumcision using primary source data from sub-Saharan Africa. PLoS One. 2014; 9(5):e84701. PMC: 4011577. DOI: 10.1371/journal.pone.0084701. View

Auvert B, Marseille E, Korenromp E, Lloyd-Smith J, Sitta R, Taljaard D . Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One. 2008; 3(8):e2679. PMC: 2475667. DOI: 10.1371/journal.pone.0002679. View

Varghese B, Maher J, Peterman T, Branson B, Steketee R . Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002; 29(1):38-43. DOI: 10.1097/00007435-200201000-00007. View

George G, Strauss M, Asfaw E . The cost of demand creation activities and voluntary medical male circumcision targeting school-going adolescents in KwaZulu-Natal, South Africa. PLoS One. 2017; 12(6):e0179854. PMC: 5478150. DOI: 10.1371/journal.pone.0179854. View

Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A . Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005; 2(11):e298. PMC: 1262556. DOI: 10.1371/journal.pmed.0020298. View

Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N . Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011; 8(11):e1001132. PMC: 3226464. DOI: 10.1371/journal.pmed.1001132. View

10.

Uthman O, Popoola T, Yahaya I, Uthman M, Aremu O . The cost-utility analysis of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a probabilistic decision model. Value Health. 2011; 14(1):70-9. DOI: 10.1016/j.jval.2010.10.011. View

11.

Leisegang R, Maartens G, Hislop M, Sargent J, Darkoh E, Cleary S . A novel Markov model projecting costs and outcomes of providing antiretroviral therapy to public patients in private practices versus public clinics in South Africa. PLoS One. 2013; 8(2):e53570. PMC: 3566152. DOI: 10.1371/journal.pone.0053570. View

12.

Boily M, Baggaley R, Wang L, Masse B, White R, Hayes R . Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009; 9(2):118-29. PMC: 4467783. DOI: 10.1016/S1473-3099(09)70021-0. View

13.

Grund J, Chetty-Makkan C, Ginindza S, Munyai R, Kisbey-Green H, Maraisane M . Effectiveness of an "Exclusive Intervention Strategy" to increase medical male circumcision uptake among men aged 25-49 years in South Africa. BMC Public Health. 2018; 18(1):868. PMC: 6044089. DOI: 10.1186/s12889-018-5729-6. View

14.

Bailey R, Moses S, Parker C, Agot K, Maclean I, Krieger J . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007; 369(9562):643-56. DOI: 10.1016/S0140-6736(07)60312-2. View

15.

Andersson K, Owens D, Paltiel A . Scaling up circumcision programs in Southern Africa: the potential impact of gender disparities and changes in condom use behaviors on heterosexual HIV transmission. AIDS Behav. 2010; 15(5):938-48. PMC: 3112296. DOI: 10.1007/s10461-010-9784-y. View

16.

Baeten J, Richardson B, Lavreys L, Rakwar J, Mandaliya K, Bwayo J . Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men. J Infect Dis. 2005; 191(4):546-53. DOI: 10.1086/427656. View

17.

Tchuenche M, Palmer E, Hate V, Thambinayagam A, Loykissoonlal D, Njeuhmeli E . Correction: The Cost of Voluntary Medical Male Circumcision in South Africa. PLoS One. 2017; 12(1):e0169710. PMC: 5207431. DOI: 10.1371/journal.pone.0169710. View

18.

Kahn J, Marseille E, Auvert B . Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006; 3(12):e517. PMC: 1716193. DOI: 10.1371/journal.pmed.0030517. View

19.

Chiu C, Johnson L, Jamieson L, Larson B, Meyer-Rath G . Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?. BMC Public Health. 2017; 17(1):143. PMC: 5282636. DOI: 10.1186/s12889-017-4023-3. View

20.

Uthman O, Popoola T, Uthman M, Aremu O . Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review. PLoS One. 2010; 5(3):e9628. PMC: 2835757. DOI: 10.1371/journal.pone.0009628. View